tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Ocular Therapeutix Inc

OCUL
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
8.630USD
+0.125+1.47%
์ข…๊ฐ€ย 07-27 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
1.51B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Ocular Therapeutix Inc

8.630
+0.125+1.47%
๊ฐœ์š”
๊ธˆ์œต
ํ† ๋ก 
๋ถ„์„
ํšŒ์‚ฌ
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

๊ฐœ์š”

๊ธˆ์œต

ํ† ๋ก 

๋ถ„์„

ํšŒ์‚ฌ

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

OCUL ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Ocular Therapeutix Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Ocular Therapeutix Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 5, 2026
EPS / ์˜ˆ์ƒ
-0.40/-0.31
์ˆ˜์ต / ์˜ˆ์ƒ
10.79M/12.60M
์˜ˆ์ •๋œ ์‹ค์  ๋ฐœํ‘œ ์ผ์ • ๋ณด๊ธฐ >>
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
51.95M
-18.47%
EPS(YoY)
-1.42
-16.16%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/07/27
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-4.57%-0.40
-0.76%-0.29
-72.72%-0.38
-48.83%-0.39
23.02%-0.38
12.93%-0.29
-3262.00%-0.22
0.37%-0.26
-25.38%-0.49
-63.82%-0.33
---0.01
---0.26
---0.39
---0.20
---0.72
----
----
----
----
----
์ˆ˜์ต
0.81%10.79M
-22.43%13.25M
-5.71%14.54M
-18.14%13.46M
-27.59%10.70M
15.41%17.08M
2.28%15.43M
8.26%16.44M
10.47%14.77M
5.16%14.80M
26.04%15.08M
23.81%15.19M
1.42%13.37M
14.36%14.07M
-1.55%11.96M
4.68%12.27M
79.61%13.19M
67.48%12.31M
106.82%12.15M
646.85%11.72M
์ˆœ์ด์ต
-38.34%-88.61M
-33.62%-64.65M
-90.22%-69.42M
-54.91%-67.81M
1.23%-64.05M
-65.60%-48.39M
-6972.29%-36.49M
-111.67%-43.78M
-113.89%-64.85M
-88.01%-29.22M
97.87%-516.00K
-10.21%-20.68M
-141.73%-30.32M
-303.69%-15.54M
-1010.35%-24.19M
-121.27%-18.77M
-501.86%-12.54M
95.50%-3.85M
122.25%2.66M
76.81%-8.48M
์ˆœ์ด์ต๋ฅ 
-37.23%-821.62%
-72.26%-487.95%
-101.75%-477.30%
-89.23%-503.86%
-36.41%-598.74%
-43.49%-283.27%
-6814.57%-236.58%
-95.51%-266.27%
-93.62%-438.93%
-78.78%-197.42%
---3.42%
---136.19%
---226.69%
---110.42%
---148.31%
----
----
----
----
----
์ด ์ด์ต๋ฅ 
-0.60%87.68%
-5.20%87.97%
-2.31%87.80%
-5.80%85.56%
-3.10%88.20%
2.39%92.80%
-1.09%89.88%
-0.65%90.82%
0.11%91.02%
-2.34%90.64%
--90.87%
--91.41%
--90.92%
--92.81%
--90.57%
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-42.30%9.84%
-40.99%8.83%
24.28%17.19%
19.30%15.49%
38.26%17.05%
-49.67%14.96%
-69.61%13.83%
-71.26%12.98%
-71.01%12.33%
-17.83%29.73%
--45.50%
--45.18%
--42.53%
--36.18%
--33.64%
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
0.81%10.79M
-22.43%13.25M
-5.71%14.54M
-18.14%13.46M
-27.59%10.70M
15.41%17.08M
2.28%15.43M
8.26%16.44M
10.47%14.77M
5.16%14.80M
26.04%15.08M
23.81%15.19M
1.42%13.37M
14.36%14.07M
-1.55%11.96M
4.68%12.27M
79.61%13.19M
67.48%12.31M
106.82%12.15M
646.85%11.72M
์˜์—… ์ด์ต
-46.03%-93.34M
-37.93%-69.76M
-49.35%-68.70M
-55.18%-67.64M
-102.16%-63.92M
-152.25%-50.58M
-139.40%-46.00M
-111.91%-43.59M
-40.21%-31.62M
-3.56%-20.05M
10.82%-19.21M
-3.28%-20.57M
-26.45%-22.55M
-7.27%-19.36M
-10.32%-21.54M
1.56%-19.92M
11.84%-17.83M
-25.84%-18.05M
-39.43%-19.53M
-13.12%-20.23M
์ˆœ์ด์ต
-38.34%-88.61M
-33.62%-64.65M
-90.22%-69.42M
-54.91%-67.81M
1.23%-64.05M
-65.60%-48.39M
-6972.29%-36.49M
-111.67%-43.78M
-113.89%-64.85M
-88.01%-29.22M
97.87%-516.00K
-10.21%-20.68M
-141.73%-30.32M
-303.69%-15.54M
-1010.35%-24.19M
-121.27%-18.77M
-501.86%-12.54M
95.50%-3.85M
122.25%2.66M
76.81%-8.48M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
82.10%706.00M
77.36%782.13M
-18.19%386.98M
-13.08%433.38M
-25.42%387.69M
89.89%440.99M
234.86%473.01M
395.06%498.58M
385.08%519.82M
79.16%232.24M
-2.99%141.26M
-37.18%100.71M
-38.64%107.16M
-32.24%129.63M
-28.60%145.62M
-25.96%160.32M
-23.44%174.65M
-22.29%191.30M
148.99%203.93M
139.80%216.52M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
25.73%47.68M
22.86%50.81M
35.58%49.29M
43.24%42.93M
56.09%37.93M
18.51%41.35M
3.69%36.36M
-7.37%29.97M
-18.23%24.30M
11.15%34.90M
19.81%35.07M
23.91%32.36M
24.02%29.71M
19.20%31.39M
16.34%29.27M
21.17%26.11M
-12.67%23.96M
-1.23%26.34M
9.83%25.16M
56.13%21.55M
์ด ์ž์‚ฐ
80.46%732.53M
76.46%808.06M
-16.21%410.88M
-12.72%451.33M
-24.68%405.92M
81.68%457.94M
201.98%490.37M
321.92%517.09M
319.18%538.95M
68.84%252.06M
2.40%162.38M
-29.19%122.56M
-31.47%128.57M
-27.14%149.29M
-27.17%158.58M
-24.98%173.07M
-22.80%187.62M
-21.76%204.89M
121.69%217.74M
115.09%230.71M
๋ถ€์ฑ„ ์ด๊ณ„
7.83%150.96M
7.82%153.75M
10.34%152.65M
4.32%145.42M
6.89%139.99M
-11.40%142.59M
-10.47%138.35M
16.68%139.40M
10.18%130.96M
41.28%160.93M
37.54%154.53M
11.38%119.47M
10.23%118.86M
-2.55%113.91M
-13.84%112.35M
-28.71%107.27M
-32.45%107.83M
-37.08%116.89M
27.41%130.40M
47.63%150.46M
์ž๋ณธ ์ด๊ณ„
118.69%581.57M
107.49%654.31M
-26.64%258.23M
-19.00%305.92M
-34.82%265.93M
246.03%315.34M
4382.63%352.02M
12135.02%377.69M
4101.25%407.98M
157.59%91.13M
-83.01%7.85M
-95.31%3.09M
-87.83%9.71M
-59.80%35.38M
-47.07%46.23M
-18.00%65.80M
-4.33%79.80M
15.64%88.00M
2216.82%87.34M
1401.63%80.25M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-47.73%-65.99M
-37.59%-54.25M
-38.75%-50.73M
-122.72%-55.24M
-31.82%-44.67M
-75.60%-39.43M
-372.83%-36.56M
-23.55%-24.80M
-69.66%-33.89M
-32.41%-22.45M
41.29%-7.73M
-84.58%-20.07M
-7.38%-19.97M
-11.91%-16.96M
-1.44%-13.17M
45.77%-10.88M
-7.15%-18.60M
-142.64%-15.15M
4.95%-12.98M
-35.55%-20.06M
์ˆœํˆฌ์ž
-141.18%-4.66M
-1305.45%-2.84M
-6633.71%-5.99M
-50.27%-1.11M
-658.04%-1.93M
55.99%-202.00K
65.64%-89.00K
62.71%-742.00K
92.45%-255.00K
78.65%-459.00K
67.38%-259.00K
-302.02%-1.99M
-1124.28%-3.38M
-240.73%-2.15M
-187.68%-794.00K
-283.72%-495.00K
-74.68%-276.00K
-149.41%-631.00K
-28.97%-276.00K
-3.20%-129.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
-92.97%294.00K
9857.37%449.38M
147.87%10.36M
4353.83%97.81M
-98.70%4.18M
-95.83%4.51M
-91.96%4.18M
-77.23%2.20M
411724.36%321.22M
23517.90%108.17M
13786.36%51.94M
1856.39%9.64M
-39.53%78.00K
-31.33%458.00K
-44.92%374.00K
-81.51%493.00K
111.10%129.00K
-99.59%667.00K
208.64%679.00K
-94.78%2.67M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Ocular Therapeutix Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 51.95M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 63.72M์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 782.13M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 77.36์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ocular Therapeutix Inc์˜ ์ด์ž์‚ฐ์€ 808.06M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 76.46์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ocular Therapeutix Inc์˜ ์ด๋ถ€์ฑ„๋Š” 153.75M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 7.82์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ocular Therapeutix Inc์˜ ์ด์ž๋ณธ์€ 654.31M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 107.49์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ocular Therapeutix Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -270.02M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -57.19์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ocular Therapeutix Inc์˜ ์ˆœํˆฌ์ž๋Š” -11.88M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -822.36์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ocular Therapeutix Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 561.72M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 69.14์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -1.42์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -16.16์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -265.94M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -37.43์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -511.90์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -68.57์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 87.35์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -4.20์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 8.83์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -40.99์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -54.85์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 42.39์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -42.01์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 22.93์ž…๋‹ˆ๋‹ค.

Ocular Therapeutix Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ocular Therapeutix Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -270.02M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -57.19์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ